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S u m m a r y
Introduction. Transperitoneal endoscopic radical prostatectomy (TERP) with extended 
pelvic lymph nodes dissection should be performed if the risk of lymph nodes involve-
ment is greater than 5%. In other cases, endoscopic extraperitoneal radical prostatec-
tomy (EERP) is performed.
Aim. To evaluate the incidence of complications during endoscopic radical prostatec-
tomy performed in the Department of Urology of CMKP in 2011-2013.
Material and methods. Data of 192 men subjected to ERP were analysed. Patients were 
divided into two groups: TERP, n = 101 and EERP, n = 91. It was a retrospective analysis 
primarily of complications observed during surgery and in the early postoperative period.
Results. TERP and EERP were performed in 101 (52.6%) and 91 (47.4%) men, respec-
tively. The largest group were men aged 60 to 64 years. In the majority of patients (87%) 
based on clinical data it was concluded that the cancer was clinically confined to the 
prostate (c £ T2, N0, M0), while in the remaining patients it was thought to be locally ad-
vanced (cT ≥ 3, N0, M0). The mean duration of hospitalisation was 5 days, wherein the two 
groups presented similarly. The most common complication observed in men treated with 
TERP and EERP was bleeding requiring blood transfusions, but it usually involved every 
tenth patient in both groups.
Conclusions. Despite the abovementioned complications, we believe that endoscopic 
radical prostatectomy ensures patients’ safety. In addition, ERP supplemented with ex-
tended pelvic lymph node dissection in selected patients is not associated with the occur-
rence of serious complications.
S t r e s z c z e n i e
Wstęp. Radykalna prostatektomia (RP) powinna być uzupełniona rozległym wycięciem 
regionalnych węzłów chłonnych, jeśli ryzyko wystąpienia przerzutów jest większe niż 5% 
i wówczas wykonywana jest z dostępu przezotrzewnowego (ang. transperitoneal endo-
scopic radical prostatectomy – TERP). W pozostałych przypadkach operacja jest wyko-
nywania z dostępu pozaotrzewnowego (ang. endoscopic extraperitoneal radical prosta-
tectomy – EERP).
Cel pracy. Ocena częstości występowania powikłań podczas endoskopowej prosta-
tektomii radykalnej wykonywanej w Klinice Urologii CMKP w latach 2011-2013.
Materiał i metody. Analizą objęto dane 192 mężczyzn. Chorych podzielono na dwie 
grupy: TERP (n = 101) oraz EERP (n = 91). Analiza miała charakter retrospektywny i do-
tyczyła głównie zjawisk, które zaobserwowano podczas operacji i we wczesnym okresie 
pooperacyjnym.
Wyniki. U 101 (52,6%) chorych wykonano TERP, u 91 (47,4%) EERP. Najliczniejszą 
grupę stanowili mężczyźni w wieku 60-64 lata. U większości (87%) chorych na podstawie 
danych klinicznych uznano, że rak był klinicznie ograniczony do stercza (cT £ 2, N0, M0), 
u pozostałych uważano, że był zaawansowany miejscowo (cT ≥ 3, N0, M0). Średni czas 
trwania hospitalizacji wyniósł 5 dni, przy czym w obu grupach przedstawiał się podobnie. 
Najczęstszym powikłaniem obserwowanym u mężczyzn poddanych TERP i EERP było 
krwawienie wymagające podania masy erytrocytarnej, niemniej w obu grupach dotyczyło 
to zwykle co dziesiątego chorego.
Wnioski. Pomimo wymienionych powyżej niedoskonałości uważamy, że endoskopo-
wa prostatektomia radykalna jest operacją zapewniającą pacjentom bezpieczeństwo. Po-
nadto u wybranych chorych uzupełnienie ERP rozległą limfadenektomią również nie wiąże 
się z wystąpieniem groźnych zdarzeń dla zdrowia operowanego mężczyzny.
Address/adres:
*Sebastian Piotrowicz
Klinika Urologii CMKP
Europejskie Centrum Zdrowia Otwock
ul. Borowa 14/18, 05-400 Otwock
tel. +48 (22) 710-30-49
spiotrowicz@wp.pl
Keywords
endoscopic radical prostatectomy, 
lymph node dissection, prostate cancer, 
complications
Słowa kluczowe
endoskopowa prostatektomia radykalna, 
limfadenektomia, rak stercza, powikłania
820
Sebastian Piotrowicz
INTRODUCTION
Radical prostatectomy (RP) is a recognised meth-
od for the treatment of prostate cancer, particularly at 
an early clinical stage. It allows for the achievement 
of 5-year and 10-year overall survival rate at the level 
of 80 and 75% and biochemical relapse-free survival 
rate of 70%-90% and 60%-80%,  respectively (1, 2). 
Endoscopic radical prostatectomy (ERP) was first per-
formed in 1992 by Schuessler (3). In Poland ERP was 
introduced in 2004. In our centre ERP is the method 
of choice for selected patients with prostate cancer. In 
addition, if the risk of lymph node involvement is higher 
than 5%, this procedure is supplemented with extend-
ed regional lymph node dissection using transperitoneal 
approach (transperitoneal endoscopic radical prosta-
tectomy – TERP). In the remaining cases the operation 
is performed using extraperitoneal approach (endo-
scopic extraperitoneal radical prostatectomy – EERP). 
Endoscopic radical prostatectomy represents the domi-
nant method for the treatment of patients with prostate 
cancer in selected centres in Poland. Unfortunately, the 
number of lymph nodes removed during these opera-
tions is surprisingly low and is not consistent with the 
recommendations of the European Association of Urol-
ogy (4). Consequently, the authors did not encounter 
any account of the possible complications when this 
procedure is supplemented with extended regional 
lymph node dissection. Therefore, they decided to pres-
ent the rate of complications observed during endo-
scopic radical prostatectomy that was performed at the 
Department of Urology of the Centre of Postgraduate 
Medical Education, Poland, in 2011-2013.
AIM
To evaluate the incidence of complications during 
endoscopic radical prostatec tomy performed in the 
Department of Urology of CMKP in 2011-2013.
MATERIAL AND METHODS
The data of 192 men who underwent ERP 
in the specified period of time were analysed.
The patients were divided into two groups. The first 
one included men who underwent transperitoneal sur-
gery (TERP; n = 101), while the second one included 
men who underwent extraperitoneal surgery (EERP; 
n = 91). It was a retrospective analysis primarily of 
complications observed during surgery and in the early 
postoperative period. Negative consequences of ERP 
which appeared within 3 months of the procedure have 
also been presented.
RESULTS
In 101 (52.6%) patients TERP was performed and 
91 patients (47.4%) underwent EERP. The selection of 
the method for radical prostatectomy depended on the 
patient’s and operating urologist’s preferences. In the 
vast majority of cases transperitoneal surgery was 
performed in patients with high- or moderate-risk can-
cer (cT ≥ 2b and/or PSA ≥ 10 ng/ml and/or Gl.s. ≥ 7).
The men who underwent surgery were 44 to 
76 years old. The largest group were men aged 60 to 
64 years (tab. 1).
Tab. 1. Age structure of men who underwent endoscopic radi-
cal prostatectomy (ERP)
Age (years)
ERP
Number of 
operated patients Percent
47-49 3 1.6
50-54 21 10.9
55-59 34 17.7
60-64 63 32.8
65-69 45 23.4
70-74 21 10.9
> 74 5 2.6
Total 192 100.0%
Mean PSA and PSA density (PSAD) levels were 
higher in men who underwent TERP than those who 
underwent EERP. Similarly, in the TERP group abnor-
malities in physical examination (DRE) and transrectal 
ultrasound examination were more common. In the 
majority of patients (87%), based on clinical data, the 
cancer was considered to be clinically limited to the 
prostate (cT £ 2, N0, M0). In the remaining patients it 
was thought to be locally advanced (cT ≥ 3, N0, M0). 
In one case EERP was performed instead of TERP 
due to the risk of bleeding associated with congenital 
thrombocytopaenia. In men who underwent TERP can-
cer turned out to be locally advanced more frequently 
and was characterised by higher malignancy as rated 
on the Gleason scale (tab. 2).
The mean duration of hospital stay was 5 days and 
it was similar in both groups. The most common com-
plication observed in men undergoing TERP and EERP 
was bleeding requiring the administration of packed 
red blood cells; however, this was usually the case in 
every tenth patient in both groups. The remaining ad-
verse events were observed extremely rarely (tab. 3). 
No complications rated as grade IIIb or higher on the 
Clavien-Dindo scale were recorded.
DISCUSSION
Radical prostatectomy is the method of choice for 
a selected group of operated patients. The present 
progress in minimally invasive surgery allows for the ex-
tension of indications for radical treatment without sig-
nificantly increasing the risk of intra- and perioperative 
complications, and, consequently, without significantly 
compromising the quality of life of the operated men. 
The presence of metastases in lymph nodes in men 
with cancer clinically confined to the organ of origin 
is a negative prognostic factor (5-7). Appropriate and 
early diagnosis of these lymph node lesions allows for 
the introduction of adjuvant therapy; however, currently, 
the majority of imaging examinations are not sufficiently 
reliable yet for the assessment of lymph nodes (8, 9). 
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Therefore, at present, pelvic lymphadenectomy re-
mains the most precise method for prostate cancer 
staging in the case of lymph node metastasis (10).
In our Department radical prostatectomy is supple-
mented with extended lymphadenectomy if the risk of 
lymph node involvement exceeds 5%. The aim of the 
paper was to assess the rate of complications which 
may occur after endoscopic prostatectomy, includ-
ing for those patients in whom radical prostatectomy 
was supplemented with extended lymphadenectomy. 
Please note that all procedures were performed by one 
surgeon.
In over half of the operated men (52.6%) ERP was 
supplemented with extended lymphadenectomy. The 
oncological type of cancer, level of malignancy and 
staging assessed both in imaging and physical exami-
nations was less favourable in this group of the oper-
ated men.
The most common postoperative complication ob-
served in patients undergoing ERP was bleeding that 
required packed red blood cells transfusion; however, 
this was usually the case in every tenth patient in both 
groups and no man required intraoperative transfu-
sion. Another complication was rectal damage which 
occurred in 2.6% of the operated men. In all cases it 
was diagnosed intraoperatively and treated endoscop-
ically. As a result, in 4 patients parenteral nutrition was 
applied. No operated patient developed anal fistula. 
Lein et al. presented the risk of rectal damage to be 
similar (3.3%) in a group of 1000 patients undergoing 
endoscopic surgery (11).
Vesicourethral anastomosis was performed using 
a continuous suture and its integrity was checked in-
traoperatively by the administration of 250 ml of saline. 
In 3 patients (1.6%) anastomotic leakage was found 
and cystography was performed before the removal 
of a Foley catheter from the urinary bladder. In the re-
maining patients the catheter was removed on the 10th 
day after the operation. In the source cited above anas-
tomotic leakage was found in 22.3% of the operated 
patients during routine cystography performed on the 
5th and 6th day after the procedure (11).
At present, the number of complications following 
pelvic lymphadenectomy is not significant and per-
forming extended pelvic lymphadenectomy does not 
have a negative effect on the number of complications 
either. Heidenreich et al. compared groups of patients 
undergoing limited and extended lymph node dissec-
tion and did not find any difference in the rate of com-
plications, which was 9% in both groups (12). However, 
extended pelvic lymphadenectomy increases the rate 
of detection of metastasis in lymph nodes by 15-30% 
compared to limited pelvic lymphadenectomy (13, 14). 
Allaf et al. demonstrated that in a group of patients 
who underwent extended lymphadenectomy in whom 
lymph node lesions accounted for less than 15% of 
the dissected nodes 5-year biochemical relapse-free 
survival was 43%, while for men who underwent lim-
ited lymphadenectomy this type of survival rate was 
only 10% (15).
Extended lymphadenectomy is associated with 
a higher risk of chylothorax. However, transperitoneal 
surgical approach enables one to take advantage of 
the peritoneal function; as a result, the occurrence of 
lymphocele is extremely rare. The draining tube was 
removed on the 2nd day after the operation once the 
level of creatinine in the collected fluid was measured. 
In our material lymphocele requiring transcutaneous 
drainage was found in one patient who was treated 
using the transperitoneal approach. Extended region-
al lymph node dissection may also result in transient 
Tab. 2.  Characteristics of the analysed group
TERP EERP Total
Number of men 101 91 192
Age (mean ± SD) 62.3 ± 6.9 62.4 ± 5.7 62.3 ± 6.3
PSA (mean ± SD) 11.9 ± 11.6 6.9 ± 3.6 9.5 ± 9.1
PSAD (mean ± SD) 0.48 ± 0.21 0.19 ± 0.1 0.28 ± 0.19
Prostate volume (mean 
± SD) 43.4 ± 19.9 42.7 ± 21.1 43.0 ± 20.5
Abnormal DRE 90 (89%) 38 (42%) 128 (67%)
Abnormal TRUS 61 (60%) 21 (23%) 82 (43%)
Cancer staging based on clinical data
Cancer limited to the 
prostate 
77 (76%) 90 (99%) 167 (87%)
Locally advanced cancer 24 (24%) 1 (1%) 25 (13%)
Cancer malignancy rated 
after biopsy (Gleason 
score, mean ± SD) 
7.09 ± 0.8 6.13 ± 0.9 6.61 ± 1.0
Cancer staging after surgery
Cancer limited to the 
prostate
58 (57%) 66 (73%) 124 (65%)
Extraprostatic infiltration 21 (21%) 19 (21%) 40 (21%)
Seminal vesicle 
involvement
21 (21%) 6 (6%) 27 (14%)
Adjacent structure 
involvement
1 (1%) 0 1 (0.5%)
Pelvic lymph node 
involvement
13 (13%) 0 13 (7%)
Cancer malignancy 
(Gleason score, 
mean ± SD)
7.0 ± 0.9 6.1 ± 0.9 6.6 ± 1.0
Tab. 3. Adverse events observed in the patients depending on 
the type of ERP
TERP EERP Total
Duration of hospital stay 
(days)
4.8 ± 1.7 5.7 ± 2.5 5.2 ± 2.1
Need for packed red 
blood cells transfusion
9 (9%) 12 (13%) 21 (11%)
Lymphocele 1 (1%) 0 1 (0.5%)
Anastomotic leak 1 (1%) 2 (2%) 3 (1.6%)
Rectal damage 1 (1%) 4 (4%) 5 (2.6%)
Parenteral nutrition 1 (1%) 3 (3%) 4 (2%)
Ileus 1 (1%) 0 1 (1%)
Neurological disorders 1 (1%) 0 1 (1%)
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neural transmission dysfunction. In one man transient 
parestesias in the lower extremity were found. In our 
analysis grade I to IIIa complications on the Clavien-
-Dindo scale were recorded.
Endoscopic prostatectomy appears to be a safe 
method free from dangerous complications; howev-
er, we are aware of the shortcomings of our study. 
First and foremost, the paper is of a retrospective na-
ture. Moreover, the subject of the study was the as-
sessment of intraoperative and early postoperative 
complications, which excludes the evaluation of the 
operated patients’ quality of life and oncological suc-
cess. It is a well-known fact that health related quality 
of life (HRQoL) is primarily compromised by erectile 
dysfunction and urinary incontinence following surgi-
cal prostatectomy.
CONCLUSIONS
Despite the shortcomings mentioned above we 
believe that endoscopic radical prostatectomy is 
a procedure that ensures patient safety. In addi-
tion, combining ERP with extended lymphadenec-
tomy in selected patients is not associated with any 
dangerous complications.
Finally, minimally invasive surgery is associated 
with short hospitalisation and faster recovery.
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